<DOC>
	<DOC>NCT02986087</DOC>
	<brief_summary>Tracheal occlusion IDE approved by FDA for severe congenital diaphragmatic hernia fetuses.</brief_summary>
	<brief_title>Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Left Congenital Diaphragmatic Hernia</brief_title>
	<detailed_description>Fetuses with severe congenital diaphragmatic hernia with an observed to expected lung ratio of &lt;25%, LHR &lt;1, singleton pregnancy, no known other anomalies, gestational age &lt; 29 weeks 6 days, no maternal disease, maternal age &gt; 18 years old meet criteria to be offered tracheal occlusion. We want to test feasibility and efficacy in our center as a requirement to enter the TOTAL trial.</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia, Diaphragmatic</mesh_term>
	<mesh_term>Hernias, Diaphragmatic, Congenital</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<criteria>Isolated CDH with liver up Severe pulmonary hypoplasia with ultrasound O/E LHR &lt;25% at the time of surgery Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days Maternal age greater than or equal to 18 years Gestational age at enrollment prior to 29 weeks 6 days Normal karyotype or FISH Normal fetal echocardiogram Singleton pregnancy Willing to remain in the greater Cincinnati area for remainder of pregnancy Family considered and decline option of termination of the pregnancy at less than 24 weeks 0 days Family meets psychosocial criteria Patient &lt; 18 years old Multifetal pregnancy Rubber latex allergy Preterm labor, cervix shortened (&lt;15 mm) or uterine anomaly strongly predisposing to preterm labor, placenta previa Right sided CDH, Bilateral CDH, isolated left sided CDH with an O/E &gt; 25% Additional fetal anomaly by ultrasound, MRI, or echocardiogram Chromosomal abnormalities Maternal contraindications to fetoscopic surgery or severe maternal condition in pregnancy Incompetent cervix with or without a cerclage Placental abnormalities known at time of enrollment Maternal HIV, Hepatits B, Hepatitis C Maternal uterine anomaly No safe or technically feasible fetoscopic approach to balloon placement Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>